Company Filing History:
Years Active: 2000-2011
Title: Andrea Amalfitano: Innovator in Proliferative Disease Research
Introduction
Andrea Amalfitano is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of medical research. He holds a total of 9 patents, focusing primarily on methods related to proliferative diseases. His innovative approaches have the potential to impact the diagnosis and treatment of various health conditions.
Latest Patents
Among his latest patents, one notable invention is a method of screening for risk factors associated with proliferative diseases. This method involves detecting the presence or absence of upregulation of the CLN3 gene in a subject. The upregulation of the CLN3 gene indicates an increased risk of developing a proliferative disease. Additionally, he has developed methods for screening compounds aimed at treating proliferative diseases based on the CLN3 gene and its product. Another significant patent involves viral vectors and methods for producing and utilizing a recombinant hybrid virus, which includes a deleted adenovirus vector genome and a recombinant adeno-associated virus (AAV) vector genome.
Career Highlights
Andrea Amalfitano has had a distinguished career, working at esteemed institutions such as Duke University and the University of Michigan. His research has garnered attention for its innovative approaches to understanding and treating proliferative diseases.
Collaborations
Throughout his career, Amalfitano has collaborated with notable colleagues, including Yuan Tsong Chen and Huimin Hu, who is a prominent woman in the field. These collaborations have further enriched his research and contributions to medical science.
Conclusion
Andrea Amalfitano's work in the realm of proliferative diseases showcases his dedication to advancing medical research through innovation. His patents and collaborations reflect a commitment to improving health outcomes and understanding complex biological processes.